Scientific deep-dive

Does Your GLP-1 Wear Off Before the Next Dose?

Half of each dose is still present when the next one is due. The label puts semaglutide's elimination half-life at roughly seven days, tirzepatide's at about five. That is a slope, not a cliff.

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
6 min read·2 citations

A lot of people say the same thing: the first few days after the injection feel different from the last few. The pharmacology does not predict a cliff. Semaglutide’s elimination half-life is about one week,[1] and tirzepatide’s is about five days[2] — on a weekly schedule that produces a gentle slope between doses, not a drop-off. So the experience is real and common, and the explanation is probably not that the drug has run out.

What a one-week half-life actually means

A half-life is the time it takes for half the drug to leave. If semaglutide’s is roughly a week and you inject weekly, then by the time the next dose is due, roughly half of the previous one is still there — and the new dose lands on top of what remains.

That is why these drugs take weeks to reach full effect at any given dose, and it is why the label says semaglutide remains in circulation for five to seven weeks after a final injection.[1] A drug that lingers for over a month is not a drug that empties out by Friday.

By the time your next dose is due, about half the last one is still working.

Tirzepatide’s five-day half-life makes its weekly swing slightly wider than semaglutide’s, which is a real difference and still a slope rather than a step. Our dose plotter draws the curve from these figures if you want to see the shape rather than read about it.

So what are people feeling?

Several things fit the pattern better than the drug disappearing, and more than one can be true at once.

  1. The side effects fade before the appetite effect does. Nausea is usually worst in the day or two after an injection. If eating was unappealing early in the week partly because you felt queasy, appetite returning later is the nausea lifting rather than the drug failing.
  2. The dose is genuinely too low for you. A dose that controls appetite for four days and not seven is a dose worth discussing — not because the drug wears off, but because the level it holds you at may be under what you need. That is a titration conversation, and it belongs with your prescriber.
  3. Expectation shapes what you notice. Once someone believes days five to seven are the hard ones, hunger on day six gets attributed to the schedule and hunger on day two does not. This is not the same as imagining it.
  4. Ordinary life is not evenly distributed across the week. Weekends, social eating, sleep debt and stress do not fall randomly, and most people inject on the same day every week — which lines those things up with the same point in the cycle every time.
The fourth one is worth sitting with. If you inject on Monday, your “day six” is always Saturday. Any weekly rhythm in your eating — and most people have one — will map perfectly onto the dosing cycle and look like pharmacology. Changing injection day for a few weeks is the cheapest way to find out, and it is a question worth putting to your prescriber rather than acting on alone.

What not to do about it

Splitting the weekly dose into two half-doses to “smooth it out” is a common suggestion online and is not something to do on your own. It changes the concentration curve, it is not how the drug was studied, and with a compounded vial it compounds an uncertainty you already have — see what is in a compounded vial.

Taking the next dose early has the same problem from the other direction. Doses landing closer together raise the level you are held at, which is a titration decision with a labeled schedule behind it. Our titration planner prints your drug’s own schedule, which is a better thing to bring to an appointment than a description of how Thursdays feel.

When it is worth raising

  • If the pattern is consistent over several weeks, that is information, and worth describing precisely: which days, what changes, how much.
  • If weight loss has genuinely stalled rather than the feeling changing, that is a different conversation with different answers.
  • If you are missing or delaying doses, the curve really does sag — our missed dose guide covers what the labels say about timing.

Frequently Asked Questions

Not in the way the phrase suggests. Its elimination half-life is about one week, so roughly half of each dose is still present when the next is due, and the label notes it stays in circulation for five to seven weeks after a final injection. That produces a gentle slope between doses rather than a cliff.
Several things fit better than the drug running out: nausea fades before the appetite effect does, so appetite returning can be the side effect lifting; the dose may genuinely be too low for you; expectation shapes what gets noticed; and because most people inject on the same weekday, any weekly rhythm in eating lines up exactly with the dosing cycle.
Slightly. Its half-life is about five days against semaglutide's one week, so the swing between doses is a little wider. It is still a slope rather than a step.
Not on your own. Splitting changes the concentration curve, it is not how the drug was studied, and with a compounded vial it adds to an uncertainty about concentration you may already have. Raise it with your prescriber instead.
Changing injection day for a few weeks separates the two, since your 'day six' currently falls on the same weekday every time. It is a reasonable question to put to your prescriber rather than something to change unilaterally.

References

  1. 1.Novo Nordisk Inc. WEGOVY (semaglutide) — US Prescribing Information, Section 12.3 Pharmacokinetics: elimination half-life approximately 1 week (revised 06/2026) DailyMed (FDA-approved labeling). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. 2.Eli Lilly and Company. ZEPBOUND (tirzepatide) — US Prescribing Information: half-life of tirzepatide of approximately 5 days (SPL effective 2026-04-22) DailyMed (FDA-approved labeling). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b

Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.3

SnagRx

Semaglutide at $99/month, 48% below the typical price

9.3

Embody

Knowing which pharmacy fills the vial: it names RedRock Pharmacy

8.2

YourEra

Semaglutide at $99/month, 63% below the typical price